Source link : https://www.newshealth.biz/health-news/combination-therapy-looks-promising-for-hepatitis-d/
The combination of the antiviral bulevirtide (Hepcludex) plus pegylated interferon alfa-2a was superior to bulevirtide monotherapy for chronic hepatitis delta (HDV) infection, a multinational phase 2b open-label study in Europe found. The combination resulted in higher rates of HDV RNA suppression levels at 24 weeks after end of treatment, especially at a higher, 10-mg dose […]
Author : News Health
Publish date : 2024-07-16 09:03:51
Copyright for syndicated content belongs to the linked Source.
Categories